Acute and chronic effects of the neuroactive steroid pregnanolone on schedule-controlled responding in rhesus monkeys

L. R. McMahon, Charles P France

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

This study used schedule-controlled responding to examine the acute and chronic effects of the neuroactive steroid and positive γ-aminobutyric acid A (GABAA) modulator pregnanolone. Pregnanolone, the positive GABAA modulator triazolam, the GABAA chloride channel site antagonist pentylenetetrazol (PTZ) and the N-methyl-D-aspartate (NMDA) antagonist ketamine were administered to monkeys (n = 4) responding under a multiple fixed ratio (FR/FR) schedule of food presentation and stimulus shock termination (SST), before, during and after daily treatment with pregnanolone (3.2 mg/kg subcutaneously). Pregnanolone decreased responding in a dose- and time-related manner, with a duration of action of < 2h. Mutual antagonism occurred between pregnanolone and PTZ in the food component, and PTZ antagonized pregnanolone in the SST component. Daily treatment with pregnanolone increased the sensitivity to PTZ 24h but not 2h after daily pregnanolone administration, and daily pregnanolone treatment did not alter the sensitivity to pregnanolone, triazolam or ketamine. Baseline responding in the food component was decreased in some monkeys 24h after daily pregnanolone administration and in all monkeys 48h after discontinuation of daily pregnanolone treatment. These results suggest that positive GABAA modulation is one mechanism by which pregnanolone decreases FR responding, and that dependence resulting from daily pregnanolone treatment is not necessarily accompanied by tolerance to pregnanolone. Failure of pregnanolone to confer tolerance under these conditions might suggest that neuroadaptations at the GABAA receptor complex vary according to the site at which positive GABAA modulation occurs.

Original languageEnglish (US)
Pages (from-to)545-555
Number of pages11
JournalBehavioural Pharmacology
Volume13
Issue number7
StatePublished - Nov 2002

Fingerprint

Pregnanolone
Macaca mulatta
Appointments and Schedules
Steroids
Pentylenetetrazole
Triazolam
Haplorhini
Ketamine
Food
Shock
Aminobutyrates
Chloride Channels

Keywords

  • Dependence
  • Monkey
  • Neuroactive steroid
  • Positive GABA modulator
  • Pregnanolone
  • Schedule-controlled behavior
  • Tolerance
  • Withdrawal

ASJC Scopus subject areas

  • Pharmacology
  • Neuroscience(all)

Cite this

Acute and chronic effects of the neuroactive steroid pregnanolone on schedule-controlled responding in rhesus monkeys. / McMahon, L. R.; France, Charles P.

In: Behavioural Pharmacology, Vol. 13, No. 7, 11.2002, p. 545-555.

Research output: Contribution to journalArticle

@article{f67de36b54d9473c865929f6c499db1a,
title = "Acute and chronic effects of the neuroactive steroid pregnanolone on schedule-controlled responding in rhesus monkeys",
abstract = "This study used schedule-controlled responding to examine the acute and chronic effects of the neuroactive steroid and positive γ-aminobutyric acid A (GABAA) modulator pregnanolone. Pregnanolone, the positive GABAA modulator triazolam, the GABAA chloride channel site antagonist pentylenetetrazol (PTZ) and the N-methyl-D-aspartate (NMDA) antagonist ketamine were administered to monkeys (n = 4) responding under a multiple fixed ratio (FR/FR) schedule of food presentation and stimulus shock termination (SST), before, during and after daily treatment with pregnanolone (3.2 mg/kg subcutaneously). Pregnanolone decreased responding in a dose- and time-related manner, with a duration of action of < 2h. Mutual antagonism occurred between pregnanolone and PTZ in the food component, and PTZ antagonized pregnanolone in the SST component. Daily treatment with pregnanolone increased the sensitivity to PTZ 24h but not 2h after daily pregnanolone administration, and daily pregnanolone treatment did not alter the sensitivity to pregnanolone, triazolam or ketamine. Baseline responding in the food component was decreased in some monkeys 24h after daily pregnanolone administration and in all monkeys 48h after discontinuation of daily pregnanolone treatment. These results suggest that positive GABAA modulation is one mechanism by which pregnanolone decreases FR responding, and that dependence resulting from daily pregnanolone treatment is not necessarily accompanied by tolerance to pregnanolone. Failure of pregnanolone to confer tolerance under these conditions might suggest that neuroadaptations at the GABAA receptor complex vary according to the site at which positive GABAA modulation occurs.",
keywords = "Dependence, Monkey, Neuroactive steroid, Positive GABA modulator, Pregnanolone, Schedule-controlled behavior, Tolerance, Withdrawal",
author = "McMahon, {L. R.} and France, {Charles P}",
year = "2002",
month = "11",
language = "English (US)",
volume = "13",
pages = "545--555",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Acute and chronic effects of the neuroactive steroid pregnanolone on schedule-controlled responding in rhesus monkeys

AU - McMahon, L. R.

AU - France, Charles P

PY - 2002/11

Y1 - 2002/11

N2 - This study used schedule-controlled responding to examine the acute and chronic effects of the neuroactive steroid and positive γ-aminobutyric acid A (GABAA) modulator pregnanolone. Pregnanolone, the positive GABAA modulator triazolam, the GABAA chloride channel site antagonist pentylenetetrazol (PTZ) and the N-methyl-D-aspartate (NMDA) antagonist ketamine were administered to monkeys (n = 4) responding under a multiple fixed ratio (FR/FR) schedule of food presentation and stimulus shock termination (SST), before, during and after daily treatment with pregnanolone (3.2 mg/kg subcutaneously). Pregnanolone decreased responding in a dose- and time-related manner, with a duration of action of < 2h. Mutual antagonism occurred between pregnanolone and PTZ in the food component, and PTZ antagonized pregnanolone in the SST component. Daily treatment with pregnanolone increased the sensitivity to PTZ 24h but not 2h after daily pregnanolone administration, and daily pregnanolone treatment did not alter the sensitivity to pregnanolone, triazolam or ketamine. Baseline responding in the food component was decreased in some monkeys 24h after daily pregnanolone administration and in all monkeys 48h after discontinuation of daily pregnanolone treatment. These results suggest that positive GABAA modulation is one mechanism by which pregnanolone decreases FR responding, and that dependence resulting from daily pregnanolone treatment is not necessarily accompanied by tolerance to pregnanolone. Failure of pregnanolone to confer tolerance under these conditions might suggest that neuroadaptations at the GABAA receptor complex vary according to the site at which positive GABAA modulation occurs.

AB - This study used schedule-controlled responding to examine the acute and chronic effects of the neuroactive steroid and positive γ-aminobutyric acid A (GABAA) modulator pregnanolone. Pregnanolone, the positive GABAA modulator triazolam, the GABAA chloride channel site antagonist pentylenetetrazol (PTZ) and the N-methyl-D-aspartate (NMDA) antagonist ketamine were administered to monkeys (n = 4) responding under a multiple fixed ratio (FR/FR) schedule of food presentation and stimulus shock termination (SST), before, during and after daily treatment with pregnanolone (3.2 mg/kg subcutaneously). Pregnanolone decreased responding in a dose- and time-related manner, with a duration of action of < 2h. Mutual antagonism occurred between pregnanolone and PTZ in the food component, and PTZ antagonized pregnanolone in the SST component. Daily treatment with pregnanolone increased the sensitivity to PTZ 24h but not 2h after daily pregnanolone administration, and daily pregnanolone treatment did not alter the sensitivity to pregnanolone, triazolam or ketamine. Baseline responding in the food component was decreased in some monkeys 24h after daily pregnanolone administration and in all monkeys 48h after discontinuation of daily pregnanolone treatment. These results suggest that positive GABAA modulation is one mechanism by which pregnanolone decreases FR responding, and that dependence resulting from daily pregnanolone treatment is not necessarily accompanied by tolerance to pregnanolone. Failure of pregnanolone to confer tolerance under these conditions might suggest that neuroadaptations at the GABAA receptor complex vary according to the site at which positive GABAA modulation occurs.

KW - Dependence

KW - Monkey

KW - Neuroactive steroid

KW - Positive GABA modulator

KW - Pregnanolone

KW - Schedule-controlled behavior

KW - Tolerance

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=0036855718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036855718&partnerID=8YFLogxK

M3 - Article

C2 - 12409993

AN - SCOPUS:0036855718

VL - 13

SP - 545

EP - 555

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 7

ER -